Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne M Dorrance

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Hypertension (Dallas, Tex. : 1979)|October 24, 2012
Angiotensin II type 2 receptor agonists as therapies for ischemic strokeAnne M Dorrance
Vascular Pharmacology|July 3, 2007
Interleukin 1-beta (IL-1beta) enhances contractile responses in endothelium-denuded aorta from hypertensive, but not normotensive, ratsAnne M Dorrance
Hypertension (Dallas, Tex. : 1979)|July 29, 2009
Are macrophages the foot soldiers in the war waged by aldosterone against the heart?Anne M Dorrance
Endocrinology|July 24, 2008
Stroke therapy: is spironolactone the Holy Grail?Anne M Dorrance
F1000Prime Reports|August 29, 2014
Interfering with mineralocorticoid receptor activation: the past, present, and futureAnne M Dorrance
Current Topics in Membranes|May 14, 2020
Regulation of ion channels in the microcirculation by mineralocorticoid receptor activationLaura Chambers, Anne M Dorrance
Comprehensive Physiology|July 4, 2015
Effects of Stroke on the Autonomic Nervous SystemAnne M Dorrance, Greg Fink
Experimental Biology and Medicine (Maywood, N.J.)|March 15, 2014
Temporary mineralocorticoid receptor antagonism during the development of hypertension improves cerebral artery dilationJonathon L McClain, Anne M Dorrance
Endocrinology|October 11, 2008
11beta-hydroxysteroid dehydrogenase type II inhibition causes cerebrovascular remodeling and increases infarct size after cerebral ischemiaJessica M Osmond, Anne M Dorrance
Prostaglandins, Leukotrienes, and Essential Fatty Acids|June 20, 2006
Arachidonic acid induces augmented vasoconstriction via cyclooxygenase 1 in the aorta from rats fed a high-fat dietAnita D Smith, Anne M Dorrance
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Hypertension (Dallas, Tex. : 1979)|October 24, 2012
Angiotensin II type 2 receptor agonists as therapies for ischemic strokeAnne M Dorrance
Vascular Pharmacology|July 3, 2007
Interleukin 1-beta (IL-1beta) enhances contractile responses in endothelium-denuded aorta from hypertensive, but not normotensive, ratsAnne M Dorrance
Hypertension (Dallas, Tex. : 1979)|July 29, 2009
Are macrophages the foot soldiers in the war waged by aldosterone against the heart?Anne M Dorrance
Endocrinology|July 24, 2008
Stroke therapy: is spironolactone the Holy Grail?Anne M Dorrance
F1000Prime Reports|August 29, 2014
Interfering with mineralocorticoid receptor activation: the past, present, and futureAnne M Dorrance
Current Topics in Membranes|May 14, 2020
Regulation of ion channels in the microcirculation by mineralocorticoid receptor activationLaura Chambers, Anne M Dorrance
Comprehensive Physiology|July 4, 2015
Effects of Stroke on the Autonomic Nervous SystemAnne M Dorrance, Greg Fink
Experimental Biology and Medicine (Maywood, N.J.)|March 15, 2014
Temporary mineralocorticoid receptor antagonism during the development of hypertension improves cerebral artery dilationJonathon L McClain, Anne M Dorrance
Endocrinology|October 11, 2008
11beta-hydroxysteroid dehydrogenase type II inhibition causes cerebrovascular remodeling and increases infarct size after cerebral ischemiaJessica M Osmond, Anne M Dorrance
Prostaglandins, Leukotrienes, and Essential Fatty Acids|June 20, 2006
Arachidonic acid induces augmented vasoconstriction via cyclooxygenase 1 in the aorta from rats fed a high-fat dietAnita D Smith, Anne M Dorrance
Pageof 8